SlideShare a Scribd company logo
PLASMA MASTER FILE
PRESENTED BY : SANJAY
M.PHARM 2nd SEM
DEPARMEENT OF
PHARMACEUTICAL
SCIENCE, ROHTAK
SUBMITTED TO:
MRS. POONAM
YADAV
Assistance prof.
of
Pharmaceutics
CONTENTS
• INTRODUCTION
• PRINCILES OF PMF
• CERTIFICATION OF PMF
• REQUIREMENTS FOR INITIAL APPLICATION FOR CERTIFICATION
• CHANGES TO THE CONTENTS OF A PMF
WHAT IS PMF
It is a compilation of all the required scientific data on the quality and
safety of human plasma relevant to the medicines, medical devices and
investigational products that use human plasma in their manufacture.
In June 2003, this concept was introduced by European legislation
However this document is intended to provide guidance on the
submission, evaluation & certification of PMF
DIRECTIVE 2001/83/EC 25 JUNE 2003 DIRECTIVE 2003/63/EC
PRINCIPLES OF PMF
The aim of the PMF is to just simply the tasks of MAH & Competent
authorities:-
 reduces number of dossier submission & data evaluation for the
same plasma
 Ensure consistency throughout EC
ADMINISTRATIVE INFORMATION
• An application form for each EMEA
• A list of medicinal product to which PMF is applied
• Information of pending approval will be given
• The period of data collection should be specified
EXPERT STATEMENT SHOULD BE PROVIDED IN PMF
CERTIFICATION PROCEDURE
• 1st step:- it is similar to centralized procedure which results in a
certificate of compliance to community legislation issued by EMEA . It
is valid throughout EU
• 2nd step:-the competent authority who will or has granted the MA shall
be responsible for certification or re-certification of the PMF
Note :- if the applicant chooses the community PMF certification system, all
variation will be submitted through the same certification system
Certificate of compliance
(valid throughout the European country)
1st step
PMF certification
Product A
Using
Plasma X
Product C
Using
Plasma X
Product B
Using
Plasma X
2nd step
Impact on the
medicinal product
Concerned medicinal product in
which plasma X is used
NOTE FOR APPLICANTS:- NO VARIATION WILL BE ENTERTAINED
DURING THE CERTIFICATION PROCEDURE
Letter of intent to EMEA
 The applicant should inform the EMEA 2-3 months prior about the
certification
 Should specify the intended submission date
 The appropriate trigger for submission
 The applicant should also propose co-ordinators in their letter of intent. Then
co-ordinators will be responsible for the evaluation of PMF on behalf of
EMEA
APPOINTMENT OF CO-ORDINATORS
EMEA ISSUE A LIST OF PMF CO-ORDINATOR
• Two co-ordinators will be appointed by CPMP in consultation with
BWP. After this the appointment will be notified to the applicant
SUBMISSION AND VALIDATION
• The monthly deadline for submission of PMF application will be
published on EMEA website
• What documents are required are also published on site
• Final validation is done by EMEA
EVALUATION
• This report will be made by the appointed co-ordinators & circulated for review by
BWP. Then it will make appropriate recommendations
Timetable
Day -10 EMEA validation of the PMF application
Day 0 clock start(at official CPMP start date)
Day 30 CPMP inspection
Day 45 circulation of co-ordinators report to BWP & then from EMEA to
applicant
Day 75 comments BWP members
Day 83 BWP discussion/recommendation
Day 90 CPMP adoption of the evaluation report
• INSPECTION:- If necessary to complete the assessment of the
submitted PMF,
• CERTIFICATION :- After evaluation by CPMP, the EMEA issue PMF
certificate(5 days). In this MS & applicant will be notified
Requested by by
CPMP
REPORT SENT TO
EMEA
THEN SUBMITTED TO
CPMP
plasma master file in European countries and requirements in letter of intent to European medicine Evaluation Agecncy

More Related Content

What's hot

European_Union.ppt.Nikhil[1].pptx
European_Union.ppt.Nikhil[1].pptxEuropean_Union.ppt.Nikhil[1].pptx
European_Union.ppt.Nikhil[1].pptx
NikhilBorade5
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
Sridhar S
 
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
SanthiNori1
 
National Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) CertificationNational Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) Certification
SanthiNori1
 
Organization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptxOrganization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptx
BhavikaAPatel
 
NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...
SyedArshiya4
 
IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best Practices
CFTCC
 
International Medical Device Regulators Forum
International Medical Device Regulators ForumInternational Medical Device Regulators Forum
International Medical Device Regulators Forum
SanthiNori1
 
GCC Regulatory MAA & post approval requirements (Saudi Arabia & UAE) unit-5 R...
GCC Regulatory MAA & post approval requirements (Saudi Arabia & UAE) unit-5 R...GCC Regulatory MAA & post approval requirements (Saudi Arabia & UAE) unit-5 R...
GCC Regulatory MAA & post approval requirements (Saudi Arabia & UAE) unit-5 R...
Parul Institute of Pharmacy
 
Electronic submission PPT
Electronic submission PPTElectronic submission PPT
Electronic submission PPT
Doninder Hooda
 
GHTF
GHTFGHTF
GHTF
KDivya11
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Michael Swit
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
Vikas Rathee
 
21 CFR 820 and 801 pptx.pdf
21 CFR 820 and 801 pptx.pdf21 CFR 820 and 801 pptx.pdf
21 CFR 820 and 801 pptx.pdf
BhavikaAPatel
 
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
sandeep bansal
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
JAYA PRAKASH VELUCHURI
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usVinod Raj
 
Medical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing SurvellianceMedical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing Survelliance
CSIR-URDIP, NCL Campus, Pune
 
Fda med watch
Fda med watchFda med watch
Fda med watch
Sridhar S
 
GMP for Nutraceuticals .pdf
GMP for Nutraceuticals  .pdfGMP for Nutraceuticals  .pdf
GMP for Nutraceuticals .pdf
BhavikaAPatel
 

What's hot (20)

European_Union.ppt.Nikhil[1].pptx
European_Union.ppt.Nikhil[1].pptxEuropean_Union.ppt.Nikhil[1].pptx
European_Union.ppt.Nikhil[1].pptx
 
Plasma master file
Plasma master filePlasma master file
Plasma master file
 
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
 
National Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) CertificationNational Sanitation Foundation(NSF) Certification
National Sanitation Foundation(NSF) Certification
 
Organization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptxOrganization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptx
 
NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...
 
IDE Application Process and Best Practices
IDE Application Process and Best PracticesIDE Application Process and Best Practices
IDE Application Process and Best Practices
 
International Medical Device Regulators Forum
International Medical Device Regulators ForumInternational Medical Device Regulators Forum
International Medical Device Regulators Forum
 
GCC Regulatory MAA & post approval requirements (Saudi Arabia & UAE) unit-5 R...
GCC Regulatory MAA & post approval requirements (Saudi Arabia & UAE) unit-5 R...GCC Regulatory MAA & post approval requirements (Saudi Arabia & UAE) unit-5 R...
GCC Regulatory MAA & post approval requirements (Saudi Arabia & UAE) unit-5 R...
 
Electronic submission PPT
Electronic submission PPTElectronic submission PPT
Electronic submission PPT
 
GHTF
GHTFGHTF
GHTF
 
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement ActionsLabeling/Advertising and Promotion, Import/Export, and Enforcement Actions
Labeling/Advertising and Promotion, Import/Export, and Enforcement Actions
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
 
21 CFR 820 and 801 pptx.pdf
21 CFR 820 and 801 pptx.pdf21 CFR 820 and 801 pptx.pdf
21 CFR 820 and 801 pptx.pdf
 
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
ACTIVE SUBSTANCE MSTER FILE (ASMF) eMA
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in us
 
Medical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing SurvellianceMedical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing Survelliance
 
Fda med watch
Fda med watchFda med watch
Fda med watch
 
GMP for Nutraceuticals .pdf
GMP for Nutraceuticals  .pdfGMP for Nutraceuticals  .pdf
GMP for Nutraceuticals .pdf
 

Similar to plasma master file in European countries and requirements in letter of intent to European medicine Evaluation Agecncy

Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
Shoba Elangovan
 
Regulatory aspects for registration of API in formulation
Regulatory aspects for registration of API  in formulationRegulatory aspects for registration of API  in formulation
Regulatory aspects for registration of API in formulation
Arul Packiadhas
 
Road towards GVP VII Rev II - Explanatory note updates
Road towards GVP VII Rev II - Explanatory note updatesRoad towards GVP VII Rev II - Explanatory note updates
Road towards GVP VII Rev II - Explanatory note updates
Dr. Rohith K Nair
 
European_Union.ppt.Nikhil[1]-1.pptx
European_Union.ppt.Nikhil[1]-1.pptxEuropean_Union.ppt.Nikhil[1]-1.pptx
European_Union.ppt.Nikhil[1]-1.pptx
AkshataBairagi
 
Marketing Authorization Procedure in European Union
Marketing Authorization Procedure in European UnionMarketing Authorization Procedure in European Union
Marketing Authorization Procedure in European Union
Doninder Hooda
 
Post-Market Clinical Follow Up Studies Under EU MDR and IVDR
Post-Market Clinical Follow Up Studies Under EU MDR and IVDRPost-Market Clinical Follow Up Studies Under EU MDR and IVDR
Post-Market Clinical Follow Up Studies Under EU MDR and IVDR
EMMAIntl
 
US DMF v/s European DMF
US DMF v/s European DMFUS DMF v/s European DMF
US DMF v/s European DMF
Neha Pillai
 
EU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesEU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and Differences
Merck Life Sciences
 
EU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesEU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and Differences
MilliporeSigma
 
Changes in European PV post July 2011
Changes in European PV post July 2011Changes in European PV post July 2011
Changes in European PV post July 2011
Amrutha VC
 
CMC EU GCC.pdf
CMC EU GCC.pdfCMC EU GCC.pdf
CMC EU GCC.pdf
Asmaa Khalil
 
Drug master file
Drug master file Drug master file
Drug master file
Bindu Kshtriya
 
Clinical Research Training - Dr Ruben Keane, UCC - Dec 7th 2016
Clinical Research Training - Dr Ruben Keane, UCC - Dec 7th 2016 Clinical Research Training - Dr Ruben Keane, UCC - Dec 7th 2016
Clinical Research Training - Dr Ruben Keane, UCC - Dec 7th 2016
ipposi
 
clinical-evaluation-report (CER)
clinical-evaluation-report (CER)clinical-evaluation-report (CER)
clinical-evaluation-report (CER)
PEPGRA Healthcare
 
Clinicals In The Uk 26 January 2009
Clinicals In The Uk   26 January 2009Clinicals In The Uk   26 January 2009
Clinicals In The Uk 26 January 2009
Colin Rylett
 
Audit remoto
Audit remotoAudit remoto
Audit remoto
Monica Mazzoni
 
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
TGA Australia
 
VOLUME 9A ppt.pptx
VOLUME 9A ppt.pptxVOLUME 9A ppt.pptx
VOLUME 9A ppt.pptx
AartiVats5
 
Ich
IchIch

Similar to plasma master file in European countries and requirements in letter of intent to European medicine Evaluation Agecncy (20)

Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
 
Regulatory aspects for registration of API in formulation
Regulatory aspects for registration of API  in formulationRegulatory aspects for registration of API  in formulation
Regulatory aspects for registration of API in formulation
 
Road towards GVP VII Rev II - Explanatory note updates
Road towards GVP VII Rev II - Explanatory note updatesRoad towards GVP VII Rev II - Explanatory note updates
Road towards GVP VII Rev II - Explanatory note updates
 
European_Union.ppt.Nikhil[1]-1.pptx
European_Union.ppt.Nikhil[1]-1.pptxEuropean_Union.ppt.Nikhil[1]-1.pptx
European_Union.ppt.Nikhil[1]-1.pptx
 
Marketing Authorization Procedure in European Union
Marketing Authorization Procedure in European UnionMarketing Authorization Procedure in European Union
Marketing Authorization Procedure in European Union
 
Post-Market Clinical Follow Up Studies Under EU MDR and IVDR
Post-Market Clinical Follow Up Studies Under EU MDR and IVDRPost-Market Clinical Follow Up Studies Under EU MDR and IVDR
Post-Market Clinical Follow Up Studies Under EU MDR and IVDR
 
New EU PV regulations
New EU PV regulationsNew EU PV regulations
New EU PV regulations
 
US DMF v/s European DMF
US DMF v/s European DMFUS DMF v/s European DMF
US DMF v/s European DMF
 
EU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesEU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and Differences
 
EU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and DifferencesEU and US Procedures for API Registration - Commonalities and Differences
EU and US Procedures for API Registration - Commonalities and Differences
 
Changes in European PV post July 2011
Changes in European PV post July 2011Changes in European PV post July 2011
Changes in European PV post July 2011
 
CMC EU GCC.pdf
CMC EU GCC.pdfCMC EU GCC.pdf
CMC EU GCC.pdf
 
Drug master file
Drug master file Drug master file
Drug master file
 
Clinical Research Training - Dr Ruben Keane, UCC - Dec 7th 2016
Clinical Research Training - Dr Ruben Keane, UCC - Dec 7th 2016 Clinical Research Training - Dr Ruben Keane, UCC - Dec 7th 2016
Clinical Research Training - Dr Ruben Keane, UCC - Dec 7th 2016
 
clinical-evaluation-report (CER)
clinical-evaluation-report (CER)clinical-evaluation-report (CER)
clinical-evaluation-report (CER)
 
Clinicals In The Uk 26 January 2009
Clinicals In The Uk   26 January 2009Clinicals In The Uk   26 January 2009
Clinicals In The Uk 26 January 2009
 
Audit remoto
Audit remotoAudit remoto
Audit remoto
 
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
Sponsor Information and Training day Session B1 - Medical Devices: Conformity...
 
VOLUME 9A ppt.pptx
VOLUME 9A ppt.pptxVOLUME 9A ppt.pptx
VOLUME 9A ppt.pptx
 
Ich
IchIch
Ich
 

Recently uploaded

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 

Recently uploaded (20)

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 

plasma master file in European countries and requirements in letter of intent to European medicine Evaluation Agecncy

  • 1. PLASMA MASTER FILE PRESENTED BY : SANJAY M.PHARM 2nd SEM DEPARMEENT OF PHARMACEUTICAL SCIENCE, ROHTAK SUBMITTED TO: MRS. POONAM YADAV Assistance prof. of Pharmaceutics
  • 2. CONTENTS • INTRODUCTION • PRINCILES OF PMF • CERTIFICATION OF PMF • REQUIREMENTS FOR INITIAL APPLICATION FOR CERTIFICATION • CHANGES TO THE CONTENTS OF A PMF
  • 3. WHAT IS PMF It is a compilation of all the required scientific data on the quality and safety of human plasma relevant to the medicines, medical devices and investigational products that use human plasma in their manufacture. In June 2003, this concept was introduced by European legislation However this document is intended to provide guidance on the submission, evaluation & certification of PMF
  • 4. DIRECTIVE 2001/83/EC 25 JUNE 2003 DIRECTIVE 2003/63/EC PRINCIPLES OF PMF The aim of the PMF is to just simply the tasks of MAH & Competent authorities:-  reduces number of dossier submission & data evaluation for the same plasma  Ensure consistency throughout EC
  • 5. ADMINISTRATIVE INFORMATION • An application form for each EMEA • A list of medicinal product to which PMF is applied • Information of pending approval will be given • The period of data collection should be specified EXPERT STATEMENT SHOULD BE PROVIDED IN PMF
  • 6. CERTIFICATION PROCEDURE • 1st step:- it is similar to centralized procedure which results in a certificate of compliance to community legislation issued by EMEA . It is valid throughout EU • 2nd step:-the competent authority who will or has granted the MA shall be responsible for certification or re-certification of the PMF
  • 7. Note :- if the applicant chooses the community PMF certification system, all variation will be submitted through the same certification system Certificate of compliance (valid throughout the European country) 1st step PMF certification Product A Using Plasma X Product C Using Plasma X Product B Using Plasma X 2nd step Impact on the medicinal product Concerned medicinal product in which plasma X is used
  • 8. NOTE FOR APPLICANTS:- NO VARIATION WILL BE ENTERTAINED DURING THE CERTIFICATION PROCEDURE Letter of intent to EMEA  The applicant should inform the EMEA 2-3 months prior about the certification  Should specify the intended submission date  The appropriate trigger for submission  The applicant should also propose co-ordinators in their letter of intent. Then co-ordinators will be responsible for the evaluation of PMF on behalf of EMEA
  • 9. APPOINTMENT OF CO-ORDINATORS EMEA ISSUE A LIST OF PMF CO-ORDINATOR • Two co-ordinators will be appointed by CPMP in consultation with BWP. After this the appointment will be notified to the applicant SUBMISSION AND VALIDATION • The monthly deadline for submission of PMF application will be published on EMEA website • What documents are required are also published on site • Final validation is done by EMEA
  • 10. EVALUATION • This report will be made by the appointed co-ordinators & circulated for review by BWP. Then it will make appropriate recommendations Timetable Day -10 EMEA validation of the PMF application Day 0 clock start(at official CPMP start date) Day 30 CPMP inspection Day 45 circulation of co-ordinators report to BWP & then from EMEA to applicant Day 75 comments BWP members Day 83 BWP discussion/recommendation Day 90 CPMP adoption of the evaluation report
  • 11. • INSPECTION:- If necessary to complete the assessment of the submitted PMF, • CERTIFICATION :- After evaluation by CPMP, the EMEA issue PMF certificate(5 days). In this MS & applicant will be notified Requested by by CPMP REPORT SENT TO EMEA THEN SUBMITTED TO CPMP